Connie Newman, MD, FACP, FAHA, FAMWA
Dr. Connie B. Newman, President-elect of the American Medical Women’s Association, is a graduate of Weill Cornell Medical College (Class of 1978). She is an endocrinologist, physician-scientist and Adjunct Professor of Medicine at New York University (NYU) School of Medicine, and Academic Visitor, University of Oxford, UK. She has expertise in statin safety, lipid disorders, diabetes, and obesity, and has published and lectured on statin safety and intolerance for many years. Dr. Newman is Chair of the Endocrine Society clinical practice guideline on the management of high cholesterol in people with type 2 diabetes and endocrine diseases, and Chair of the American Heart Association Scientific Statement on statin safety. She has been appointed a Consultant to the Endocrine and Metabolic Drugs Advisory Committee of the FDA. She is also a member of the Cholesterol Treatment Trialists’ Collaboration which conducts meta-analyses of large statin cardiovascular outcome trials. Committed to improving cardiovascular health by treating risk factors such as high cholesterol, diabetes, and obesity, Dr. Newman, as Co-Chair of the AMWA Preventive Medicine Task Force, is co-leading the development of a webinar and other materials for education of physicians on obesity comorbidities, pathophysiology and management.